
During the Health System Executive Summit, Candy Tsourounis, PharmD, and Elise Wozniak, PharmD got candid about the barriers and financial risk surrounding this innovative therapy.
There is is a rising chorus in Washington and across the nation for action to control increased prescription drug expenditures.






